Company: CSCIF
Filing Date: 2025-04-09
Form Type: 20-F
Source: 0001641172-25-003456
Chunk: 156

Company: COSCIENS Biopharma Inc.
Filing Date: 2025-04-09
Form: 20-F
Item: Item 6
Chunk 156
---
 a material uncertainty that raises substantial doubt about
the Company’s ability to continue as a going concern.

  (c)      Foreign        
           exchange risk  
 ──────────────────────────

The Company is exposed to foreign exchange risk due
to its investments in foreign operations whose functional currency is the Canadian Dollar. A table summarizing the impact of a 10% change
in the foreign exchange rates of the Canadian dollar against the US dollar on the financial assets and liabilities of the Company is presented
in note 23 to our consolidated financial statements included in this Annual Report on Form 20-F at Item 18.

  Item      Description                                 
  12.       of Securities Other than Equity Securities  
 ────────────────────────────────────────────────────────

  Debt        
  securities  
 ──────────────

Not
required.

  Warrants    
  and rights  
 ──────────────

Not
required.

  Other       
  securities  
 ──────────────

Not
required.

  American           
  depositary shares  
 ─────────────────────

Not
applicable.

  105  

PART
II